ZYXI Stock Risk & Deep Value Analysis
Zynex Inc
Healthcare • Medical Distribution
DVR Score
out of 10
What You Need to Know About ZYXI Stock
We analyzed Zynex Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran ZYXI through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
How Risky Is ZYXI Stock?
Overall Risk
Aggressive
Financial Risk
High
Market Risk
High
Competitive Risk
High
Execution Risk
High
Regulatory Risk
High
What Are the Red Flags for ZYXI?
- âš
Complete loss of remaining shareholder value.
- âš
Formal bankruptcy declaration or delisting from any remaining exchange.
- âš
Further deterioration of illiquid share price.
Unlock ZYXI Red Flags & Risk Warnings
Create a free account to see the full analysis
What Does Zynex Inc (ZYXI) Do?
Market Cap
$3.80M
Sector
Healthcare
Industry
Medical Distribution
Employees
1,000
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; and M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body; and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, braces for rehabilitation support for knee and wrist, and Dynacomp for cold compression therapy. Further, it develops Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser photoplethysmographic patient monitoring device; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; and fluid monitoring and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. On December 15, 2025, Zynex, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
Visit Zynex Inc WebsiteIs ZYXI Stock Undervalued?
Unlock the full AI analysis for ZYXI
Get the complete DVR score, risk analysis, and more
Does ZYXI Have a Competitive Moat?
Sign in to unlockMoat Rating
⚪ None
Moat Trend
Eroding
The company possesses no sustainable competitive advantages; any prior position has been completely eroded due to severe financial distress and operational failure.
Moat Erosion Risks
- •Complete market irrelevance.
- •Bankruptcy and liquidation.
ZYXI Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive ZYXI Stock Higher?
Near-Term (0-6 months)
- •No positive near-term catalysts identified given the current valuation.
- •Potential final liquidation proceedings or delisting from any remaining market.
Medium-Term (6-18 months)
- •No positive medium-term catalysts identified.
Long-Term (18+ months)
- •No positive long-term catalysts identified.
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for ZYXI?
- ✓
Any concrete evidence of a solvent recapitalization or significant asset acquisition (extremely unlikely).
- ✓
Official bankruptcy filings or liquidation notices.
Bull Case Analysis
See what could go right with Premium
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for ZYXI (Zynex Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.
